Press Releases

REDWOOD CITY, Calif.—HeartFlow, Inc. today announced the closing of its Series E financing, securing $240 million. The company will use the proceeds from this financing to ramp up commercial expansion of the HeartFlow® FFRct Analysis, continued technology innovation and additional clinical…
DANVERS, Mass., Feb. 13, 2018 (GLOBE NEWSWIRE) — Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today the launch of a new indication and Women's Initiative focused on heart recovery education and awareness. This Women's…
Tokyo-based Terumo Corporation has today announced an investment of £33 million in one of its subsidiary companies, Vascutek Limited, located near Glasgow.The investment has been approved for the major expansion of Vascutek’s headquarters and manufacturing facility at Inchinnan, Renfrewshire to…
WASHINGTON (Feb. 8, 2018) — Hundreds of hospitals across the United States will have access to tools and resources to help improve care and lower readmission rates for myocardial infarction (MI) patients as part of the American College of Cardiology’s expanded Patient Navigator Program: Focus MI…
COPENHAGEN, February 8, 2018 — Acesion Pharma ("Acesion" or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most common cardiac arrhythmia, announces today it has received approval to commence its first clinical study for its lead compound…
Pittsburgh, PA, February 7, 2018 — DoctorsReport.com, the new Website and mobile app that give you instant access to data doctors report from almost one million doctors’ offices across the nation, has released its current list of the nation’s 14 Influenza hot spots (by metro area) in the country…
KFAR MALAL, Israel, Feb. 5, 2018 — Medial EarlySign, a leader of machine-learning based solutions to improve non-communicable disease management, today announced the results of an additional clinical data study in the domain of diabetes — identifying diabetic patients who are at highest risk for…
DUBLIN and LEIPZIG — January 30, 2018 — Medtronic plc (NYSE: MDT) today added to its robust body of clinical evidence supporting the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) with new presentations that demonstrated durable and consistent clinical outcomes in peripheral artery disease (…
DUBLIN — January 26, 2018 — Medtronic plc (NYSE: MDT) today announced the initiation of its investigational device exemption (IDE) study for the Abre(TM) venous self-expanding stent system. The ABRE IDE Study will evaluate the safety and effectiveness of the Abre stent in subjects with…
DUBLIN — January 24, 2018 — Medtronic plc (NYSE: MDT) today announced the launch of the ENCHANT (ENdurantCHEVAR New Indication Trial) study. The post-market, non-interventional, multi-center, non-randomized, single-arm study will enroll approximately 150 patients across 25 sites in Europe and…
NEW YORK, Jan. 22, 2018 — Noted cardiologists, Jennifer H. Mieres, MD, and Stacey E. Rosen, MD, launch Heart Smart For Women; Six S.T.E.P.S. in Six Weeks To Heart- Healthy Living; a new book that demystifies the science, biology and statistics surrounding heart disease while providing a user-…
DEERFIELD, Ill. — Jan. 22, 2018 — Baxter International Inc. (NYSE: BAX), a global leader in sterile medication production and delivery, today announced the U.S. Food and Drug Administration (FDA) approval of Bivalirudin in 0.9 percent Sodium Chloride Injection (bivalirudin). Bivalirudin is a…
TITUSVILLE, N.J., Jan. 16, 2018 — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced findings from the U.S. Food and Drug Administration's (FDA) Mini-Sentinel assessment, confirming the positive safety and efficacy profile of XARELTO® (rivaroxaban) established in the…
AUSTIN, Texas, Jan. 17, 2018 — International Biophysics Corporation, a global medical device manufacturer based in Austin, Texas, announced they have received FDA 510k clearance for their FloPump 32 centrifugal disposable heart pump. The FloPump 32 is one of the smallest centrifugal pumps in the…
DUBLIN — January 16, 2018 — Medtronic plc (NYSE:MDT) today announced that the company's Neurovascular business unit received U.S. Food and Drug Administration (FDA) clearance of the Riptide(TM) Aspiration System, adding a valuable tool to the Acute Ischemic Stroke (AIS) product portfolio.The…
(NEWARK, Del. – Jan. 12) Kirk N. Garratt, M.Sc, M.D, has been appointed medical director of Christiana Care Health System’s Center for Heart & Vascular Health. Dr. Garratt succeeds Tim Gardner, M.D., who retired after 12 years of dedication to Christiana Care and the Delaware community.“Dr.…
DUBLIN — January 11, 2018 — Medtronic plc (NYSE:MDT) today announced the publication of results from the 'Spasticity In Stroke-Randomised Study' (SISTERS) trial in the Journal of Neurology, Neurosurgery & Psychiatry (JNNP). These results demonstrate the superiority of Medtronic ITB TherapySM…
DUBLIN, Ohio, January 11, 2018 — Cordis, a Cardinal Health company, and Medinol today announced that the first commercial cases using the EluNIR™ drug-eluting stent (DES) in the United States were performed at New York-Presbyterian Hospital/Columbia University Medical Center in New York City and…
FLAGSTAFF, Ariz. (JANUARY 3, 2018) — W. L. Gore & Associates, Inc. (Gore) today announced the first implant of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the United States. The successful procedure took place on December 19, 2017 at Maimonides Medical Center in New York by Robert…
DURHAM, N.C., Jan. 9, 2018 — Micell Technologies, Inc. announced the recent online publication of five-year data from the DESSOLVE I and II trials. The report, "Long-term clinical outcomes of a crystalline sirolimus-eluting coronary stent with a fully bioabsorbable polymer coating: five-year…
Jupiter, Fla. — January 8, 2018 — Excel Medical launches the first FDA-cleared patient surveillance system. The WAVE Clinical Platform is the first of its kind cleared for marketing.The WAVE Clinical Platform is an always-on remote monitoring platform that displays near real-time clinical views…